Why BioSig Technologies (BSGM) Shares Are Falling

BioSig Technologies Inc BSGM shares are trading lower by 17% to $1.99 during Thursday’s session after the company announced a $3 million registered direct offering of 1,570,683 shares at $1.91 per share.

Additionally, in a concurrent private placement, BioSig will issue unregistered warrants to purchase an equal number of shares at $1.78 per share. The warrants are immediately exercisable and will expire in five years. The total gross proceeds from the offering are expected to be around $3 million, to be used for working capital and general corporate purposes.

H.C. Wainwright & Co. is the exclusive placement agent, and the offering is expected to close around May 30, 2024, pending customary conditions.

See Also: US Q1 Economic Growth Downwardly Revised To 1.3%: Consumer Spending Falters

Should I Sell My BSGM Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Shares of BioSig Technologies have lost 86.22% year to date. This compares to the average annual return of -60.62%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. BioSig Technologies stock currently has an RSI of 86.25, indicating overbought conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

BSGM has a 52-week high of $16.40 and a 52-week low of $0.26.